Evelo Biosciences Inc (EVLO)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-11-08 | 2023-11-08 | PS Planned sale |
Chief Medical Officer Officer |
3,103
-15.4%
0.33USD 1,024 |
3,103 -15.4% | 0.33 | USD 1,024 | |
| 2023-11-08 | 2023-11-08 | PS Planned sale |
CSO, President of R&D Officer |
3,163
-10.9%
0.33USD 1,044 |
3,163 -10.9% | 0.33 | USD 1,044 | |
| 2023-11-08 | 2023-11-08 | PS Planned sale |
Chief Financial Officer Officer |
1,811
-7.5%
0.33USD 598 |
1,811 -7.5% | 0.33 | USD 598 | |
| 2023-11-08 | 2023-11-08 | PS Planned sale |
President & CEO Executive Director |
172
-1.0%
0.33USD 57 |
172 -1.0% | 0.33 | USD 57 | |
| 2023-11-03 | 2023-11-02 | PS Planned sale |
Chief Financial Officer Officer |
3,999
-18.5%
0.33USD 1,320 |
3,999 -18.5% | 0.33 | USD 1,320 | |
| 2023-11-03 | 2023-11-02 | PS Planned sale |
CSO, President of R&D Officer |
6,854
-23.5%
0.33USD 2,262 |
6,854 -23.5% | 0.33 | USD 2,262 | |
| 2023-11-03 | 2023-11-02 | PS Planned sale |
Chief Medical Officer Officer |
6,854
-33.5%
0.33USD 2,262 |
6,854 -33.5% | 0.33 | USD 2,262 | |
| 2023-09-29 | 2023-09-28 | PS Planned sale |
President & CEO Executive Director |
1,996
-10.6%
3.94USD 7,864 |
1,996 -10.6% | 3.94 | USD 7,864 | |
| 2023-08-09 | 2023-08-08 | PS Planned sale |
Chief Financial Officer Officer |
2,004
-18.1%
9.51USD 19,058 |
2,004 -18.1% | 9.51 | USD 19,058 | |
| 2023-08-09 | 2023-08-08 | PS Planned sale |
President & CEO Executive Director |
342
-8.3%
9.51USD 3,252 |
342 -8.3% | 9.51 | USD 3,252 | |
| 2023-08-09 | 2023-08-08 | PS Planned sale |
CSO, President of R&D Officer |
3,128
-15.8%
9.51USD 29,747 |
3,128 -15.8% | 9.51 | USD 29,747 | |
| 2023-08-09 | 2023-08-08 | PS Planned sale |
Chief Medical Officer Officer |
3,434
-30.2%
9.51USD 32,657 |
3,434 -30.2% | 9.51 | USD 32,657 | |
| 2023-07-13 | 2023-07-11 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
3,246,753
+474.0%
2.31USD 7,499,999 |
3,246,753 +474.0% | 2.31 | USD 7,499,999 | |
| 2023-07-13 | 2023-07-11 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
1,082,251
+263.3%
2.31USD 2,500,000 |
1,082,251 +263.3% | 2.31 | USD 2,500,000 | |
| 2023-07-13 | 2023-07-11 | B Purchase |
Flagship Ventures Fund IV General Partner LLC Large shareholder |
1,082,251
+285.1%
2.31USD 2,500,000 |
1,082,251 +285.1% | 2.31 | USD 2,500,000 | |
| 2023-06-12 | 2023-05-23 | PS Planned sale |
CSO, President of R&D Officer |
22,571
-7.9%
0.14USD 3,201 |
22,571 -7.9% | 0.14 | USD 3,201 | |
| 2023-05-10 | 2023-05-08 | PS Planned sale |
Chief Financial Officer Officer |
38,531
-29.6%
0.13USD 4,836 |
38,531 -29.6% | 0.13 | USD 4,836 | |
| 2023-05-10 | 2023-05-08 | PS Planned sale |
CSO, President of R&D Officer |
68,014
-19.3%
0.13USD 8,536 |
68,014 -19.3% | 0.13 | USD 8,536 | |
| 2023-05-10 | 2023-05-08 | PS Planned sale |
President & CEO Executive Director |
3,537
-5.7%
0.13USD 444 |
3,537 -5.7% | 0.13 | USD 444 | |
| 2023-05-10 | 2023-05-08 | PS Planned sale |
Chief Medical Officer Officer |
66,730
-40.6%
0.13USD 8,375 |
66,730 -40.6% | 0.13 | USD 8,375 |